Diagnosis and detection of smouldering multiple myeloma

Highlights from MyKE Myeloma 2019

Assessing treatment options for multiple myeloma and managing lenalidomide-refractory disease

Newly diagnosed multiple myeloma: Laying a solid foundation for improved long-term outcomes

Neurological concerns in multiple myeloma

Filtering through the options: Renal considerations in disease management

Dr Zsuzsanna Devecseri, EFPIA co-lead for PIONEER, discusses prostate cancer outcomes

Dr Thomas Abbott, EFPIA co-lead for PIONEER, discusses data sources and access to data

PIONEER research associates from both academic and industry discuss their experience of working together

Dr Mieke Van Hemelrijck explains the importance of define core outcome sets for prostate cancer

Prof Maria Ribal discusses how effective dissemination is key to PIONEER’s long-term success

Louise Fullwood explains the legal and ethical issues around data privacy within PIONEER